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Abstract
PSD95 is an abundant postsynaptic scaffold protein in
glutamatergic synapses that assembles into supercomplexes
composed of over 80 proteins including neurotransmitter
receptors, ion channels and adhesion proteins. How these
diverse constituents are organized into PSD95 supercom-
plexes in vivo is poorly understood. Here, we dissected the
supercomplexes in mice combining endogenous gene-tag-
ging, targeted mutations and quantitative biochemical
assays. Generating compound heterozygous mice with two
different gene-tags, one on each Psd95 allele, showed that
each ~1.5 MDa PSD95-containing supercomplex contains on
average two PSD95 molecules. Gene-tagging the endoge-
nous GluN1 and PSD95 with identical Flag tags revealed N-
methyl D-aspartic acid receptors (NMDARs) containing
supercomplexes that represent only 3% of the total popula-
tion of PSD95 supercomplexes, suggesting there are many
other subtypes. To determine whether this extended
population of different PSD95 supercomplexes use geneti-
cally deﬁned mechanisms to specify their assembly, we
tested the effect of ﬁve targeted mouse mutations on the
assembly of known PSD95 interactors, Kir2.3, Arc, IQsec2/
BRAG1 and Adam22. Unexpectedly, some mutations were
highly selective, whereas others caused widespread disrup-
tion, indicating that PSD95 interacting proteins are organized
hierarchically into distinct subfamilies of ~1.5 MDa super-
complexes, including a subpopulation of Kir2.3-NMDAR ion
channel-channel supercomplexes. Kir2.3-NMDAR ion chan-
nel-channel supercomplexes were found to be anatomically
restricted to particular brain regions. These data provide new
insight into the mechanisms that govern the constituents of
postsynaptic supercomplexes and the diversity of synapse
types.
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PSD95 is a scaffold protein composed of three PDZ
(PSD95, Dlg, ZO-1 homologous region) domains, an SH3
domain and a guanylate kinase domain that mediate
interactions with numerous synaptic proteins including
neurotransmitter receptors, adhesion and signalling proteins
(Husi et al. 2000; Fernandez et al. 2009; Zhu et al. 2016).
However, the size, stoichiometry and in what quaternary
molecular state PSD95 is assembled in vivo is presently
unclear (Hsueh et al. 1997; Christopherson et al. 2003;
Zeng et al. 2016). We recently reported that PSD95 resides
almost exclusively within ~1.5 MDa supercomplexes and
that NMDARs are organized into supercomplexes contain-
ing both PSD95 and PSD93 (Frank et al. 2016). Here,
using an integrated genetic and biochemical strategy, we
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show that, on average, a dimer of PSD95 hierarchically
organizes postsynaptic proteins into multiple distinct ~1.5
MDa PSD95 supercomplex subfamilies in the brain.
Materials and methods
Antibodies
The following antibodies were used in this study: mAb Flag [F3165,
(RRID:AB_259529); Sigma, St Louis, MO, USA], mAb Flag-HRP
[A8592 (RRID:AB_439702); Sigma], mAb GFP [A11120 (RRID:
AB_221568); Thermo Fisher Scientiﬁc Inc., Waltham, MA, USA],
mAb PSD95 [MA1-045 (RRID:AB_325399); Thermo], mAb PSD93
[Neuromab, 75-057 (RRID:AB_2277296)], mAb GluN1 [32-0500
(RRID:AB_2533060); Thermo], pAb IQsec2 (gift from Professor
James Casanova, University of Virginia, RRID:AB_2636960)], mAb
Adam22 [Neuromab, 75-083 (RRID:AB_10675128)], pAb Arc
[Synaptic systems, 156003 (RRID:AB_887694)], mAb Kir2.3
[Neuromab, 75-069 (RRID:AB_2130742)].
Animals
All animal experiments conformed to the British Home Ofﬁce
Regulations (Animal Scientiﬁc Procedures Act 1986; Project License
PPL80/2337 to Seth Grant), local ethical approval and NIH
guidelines. All mutant mice were made by homologous recom-
bination in embryonic stem cells. The generation of Glun1TAP
(Frank et al. 2016), Psd95TAP (Fernandez et al. 2009), Psd95/
(Migaud et al. 1998), Psd95EGFP (Broadhead et al. 2016), Psd93/
(McGee et al. 2001), Glun2b2A(CTR), Glun2a2B(CTR) (Ryan et al.
2013) and Glun2adel-CTD (gift of P. H. Seeburg and R. Sprengel)
(Sprengel et al. 1998) strains of mice were previously reported.
Since the proteins under investigation showed no sex dimorphism,
male and female mice were used for biochemical assays.
Blue native and SDS-PAGE immunoblot
Adult (P56-70) mouse forebrains (cortex and hippocampus) were
dissected and homogenized in buffer H (1 mM Na HEPES pH7.4,
320 mM sucrose with protease inhibitors). Samples were collected
for sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE). The homogenate pellet was collected by centrifuga-
tion with 1168 g. (MLA-80, 5000 rpm) at 2°C for 10 min and re-
homogenized (6 strokes) in 2 mL buffer H and centrifuged as
before. Pooled ﬁrst and second 1168 g. supernatants were cen-
trifuged at 16860 g. (MLA80, 19 000 rpm) to pellet the crude
membranes. Crude membranes were re-suspended in 2.5 mL buffer
H and extracted with 2.5 mL buffer X (1% Na deoxycholate,
100 mM NaCl, 50 mM tris.Cl pH8) for 1 h at 6–10°C. Next,
insoluble and non-speciﬁcally aggregated proteins were removed
from the total extract by centrifugation at 116760 g. (MLA-80,
50 000 rpm) for 40 min at 8°C. Samples were collected for blue
native PAGE (BNP) and immediately run according to Schagger
(Schagger 2001) followed by immunoblot.
Immunohistochemistry
Immunohistochemistry of homozygous PSD95 knockout (Psd95/)
and wildtype mice was carried out as recently described (Frank et al.
2016). Kir2.3 (Neuromab, 75-069) and synapsin 1 (Thermoﬁsher,
OPA1-04001) were both used at 1 : 200 dilution.
Brain region-specific purification of TAP-tagged GluN1
supercomplexes
Adult (P56-P150) Glun1TAP/TAP mouse forebrains were collected
and immediately cut into 400 lm coronal sections using a McIlwain
‘tissue chopper’. Two anatomical samples were collected and ﬂash
frozen: (i) striatum including the cordate putamen, olfactory tubercle
and piriform cortex, and (ii) the posterior cortex and hippocampus.
About 240-320 mg tissue from 3 to 5 animals was used in each
puriﬁcation. The volumes of all buffers were scaled to the brain
tissue weight as indicated below. Samples were homogenized (12
strokes with a Teﬂon-glass pestle and mortar) in 21.5 lL/mg buffer
H (1 mM Na HEPES pH7.4, 320 mM sucrose with protease
inhibitors). The homogenate pellet was collected by centrifugation
with 1168 g. (MLA-80, 5000 rpm) at 2°C for 10 min and re-
homogenized (6 strokes) in 8 lL/mg buffer H. The ﬁrst and second
1168 g. supernatants were pooled and centrifuged at 16860 g.
(MLA80, 19 000 rpm) to pellet the crude synaptoneurosome
membranes. The pellet was re-suspended in 10 lL/mg buffer H
and extracted with 10 lL/mg 2% deoxycholate, 100 mM NaCl,
50 mM Tris.Cl pH8 for 1 h at 6°C. Total extract was centrifuged at
120 000 g. for 40 min at 8°C; 70 lg/mg mouse Flag antibody
was coupled to 33 lg/mg protein G magnetic beads (Invitrogen).
Receptor was captured from extract supernatant for 2 h. The
beads were washed three times with 5 lL/mg wash buffer (0.37%
w/v sodium deoxycholate, 0.05 mg/mL lipids [1 : 1 : 3 POPC:
POPE:POG (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, 1-palmitoyl-
2-oleoyl-sn-glycero-3-phospho-(10-rac-glycerol)], 150 mM NaCl,
50 mM Tris.Cl pH8). Flag captured complexes were eluted with
2.6 lL/mg wash buffer supplemented with 0.2 mg/mL Flag peptide
for 2 h at 6°C. Eluate was buffer exchanged and concentrated with a
100-kDa MWCO (molecular weight cutt off) centrifugal ﬁlter
(Merck, Darmstadt, Germany) to 20 lL for BNP immunoblot.
Statistical analysis
All experiments were performed using at least six biological and two
technical replicates. Student’s t-test was used to compare two
experimental groups. p values < 0.05 were considered as statisti-
cally signiﬁcant.
Results
Using targeted genetic tags to quantify 1:17 molar ratio of
NMDAR to PSD95 in the mouse forebrain
We recently reported that NMDARs were partitioned between
~0.8 MDa tetrameric ion channel complexes and ~1.5 MDa
supercomplexes (hereafter referred to as 0.8-NR and 1.5-NR
respectively), whereas almost all forebrain PSD95 was
retained within ~1.5 MDa supercomplexes (hereafter referred
to as 1.5-PSD95) (Frank et al. 2016). To quantify the molar
ratio of PSD95 and NMDARs, we used two knockin mouse
lines where the PSD95 and the obligatory subunit of
NMDARs, GluN1, were tagged with an identical 3xFlag tag
targeted to the genes encoding these proteins (Glun1TAP/TAP
and Psd95TAP/TAP, respectively) (Frank et al. 2016). In dot-
blots and SDS-PAGE immunoblots, no Flag was detected in
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wildtype mouse total forebrain, whereas that in Glun1TAP/TAP
and Psd95TAP/TAP mice indicated the amount of PSD95 and
GluN1, respectively (Fig. 1a). The intensity measured by
densitometry of immuno-dotblots from Glun1TAP/TAP mouse
forebrains is 6  1% that of Psd95TAP/TAP, which corre-
sponds to a 17  3 fold (mean  SD) molar excess of
PSD95 over GluN1 (Fig. 1a and b). Since ~50% of GluN1
subunits are assembled with PSD95 (Frank et al. 2016), 1.5-
NRs represent a ~3% subset of an extended family of ~1.5
MDa supercomplexes containing PSD95.
Using mouse genetics to measure the oligomeric state of
PSD95 in ~1.5 MDa supercomplexes
It is possible that multiple copies or oligomers of PSD95 are
found in each 1.5-PSD95 (Hsueh et al. 1997; Christopherson
et al. 2003; Zhu et al. 2016). To measure the average
number of PSD95 molecules in each ~1.5 MDa supercom-
plex in the mouse forebrain, we targeted two different tags,
3xFlag (Fernandez et al. 2009) and GFP (Broadhead et al.
2016); one to each allele of the gene encoding PSD95
(Psd95) to produce a compound heterozygous knockin line,
Psd95TAP/EGFP (Fig. 2a). Since equal expression of both
alleles is expected in each cell, observing the ratio of co-
assembly of PSD95-TAP and PSD95-GFP in forebrain
extracts gave a direct measure of the average number of
PSD95 molecules in each complex. If only a single molecule
of PSD95 were required in each complex, immuno-capture
of PSD95-GFP with anti-GFP antibody would co-purify
none of the TAP-tagged PSD95. If on average two, three or
four molecules of PSD95 assemble in each complex, 50%,
75% or 87.5% PSD95-TAP would be co-captured with
PSD95-GFP respectively (Fig. 2b). As seen in Fig. 2c–f
when all PSD95-GFP was immuno-captured, 49  3%
(mean  SD) PSD95-TAP was co-puriﬁed, indicating that
each complex contains on average two molecules of PSD95.
~1.5 MDa NMDAR supercomplexes contain both PSD95
and PSD93 (Frank et al. 2016). In accordance, serial puriﬁ-
cation of 39Flag and GFP from Psd95TAP/EGFP compound
heterozygous mice showed that dimers of PSD95 also contain
NMDAR and PSD93 (Fig 2f). The mass of a dimer of
PSD95 is ~170 kDa, thus the remaining mass of 1.5-PSD95
must be occupied by other proteins.
Genetic and biochemical dissection of NMDAR and PSD95
supercomplex subfamilies
Mass spectrometric analysis of 1.5-NR and 1.5-PSD95
supercomplexes identiﬁed 55 and 79 different proteins,
respectively (Fernandez et al. 2009; Frank et al. 2016), with
89% identity. To determine whether the constituents of 1.5-
NR and 1.5-PSD95 are in overlapping or separable popula-
tions of supercomplexes, we focussed on four constituents of
1.5-NR and 1.5-PSD95 that were readily detected by blue
native PAGE (BNP) immunoblot in wildtype forebrain
extract (Frank et al. 2016): the inward-rectifying potassium
channel, Kir2.3, an ARF-GEF signalling cofactor, IQsec2/
Brag1, an immediate early gene product, Arc/Arg3.1, and a
trans-synaptic adhesion protein, Adam22 (Fig. 3a, left most
two lanes). Immunoblots show each of these proteins were
partitioned into multiple distinct assemblies that all included
a discrete band migrating with masses that ranged from 1.2 to
Fig. 1 Quantiﬁcation of the GluN1/PSD95 relative abundance in vivo
gave a 17 : 1 molar ratio of PSD95 over GluN1. (a) GluN1 and PSD95
were detected by sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE) (lower panel) and triplicate dot blot (DB) Flag immunoblot (upper
panel) of Glun1TAP/TAP, Psd95TAP/TAP mouse forebrains respectively.
The TAP-GluN1 and PSD95-TAP SDS-PAGE bands are similar to their
counterparts in singularly TAP-tagged mice (Psd95TAP/TAP and Glun1-
TAP/TAP), which indicates equal loading. (b) The molar ratio of Flag from
Psd95TAP/TAPandGlun1TAP/TAPwasquantiﬁeddensitometrically using a
dilution series, in which Psd95TAP/TAP forebrain extracts were diluted
with that of wildtype. Densitometry of dilution series indicated TAP-
PSD95 was 17  3-fold (mean  SD) more concentrated than TAP-
GluN1.
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Fig. 2 Quantiﬁcation of the in vivo stoichiometry of PSD95 in each 1.5-
PSD95 using compound heterozygous knockin tags (Psd95TAP/GFP). (a)
Schematic showing the gene structure of the last protein coding exon
(exon 20) of Psd95 in Psd95TAP/GFP hybrid mutant mice. Equal
expression of both alleles is expected in each cell because Psd95 is
on an autosomal chromosome (Chr 11). (b) Schematic showing the
expected partitioning of TAP-tagged PSD95 between captured (resin)
and ﬂow-through (unbound) in a GFP immunoprecipitation (IP) from
Psd95TAP/GFP hybridmutant forebrain extract. Only PSD95-TAP assem-
blies containing at least one PSD95-GFP will be captured and the
expected distribution ofPSD95-TAPandPSD95-GFPsubunits between
captured and ﬂow-through samples is depicted for different homo-
oligomeric states of 1.5-PSD95 containing on average: 1 (monomer), 2
(dimer), 3 (trimer) or 4 (tetramer) PSD95 molecules. This partitioning,
indicated as the percentage split for PSD95-TAP captured and in the
ﬂow-through, is dependent on the stoichiometry of PSD95 molecules in
each complex. Green and cyan ellipses correspond to PSD95-GFP and
PSD95-TAP subunits, respectively. For each oligomeric state, all
possible assemblies containing different combinations of GFP- and
TAP-tagged PDS95 are shown. (c) Dilution series of Psd95TAP/GFP
forebrain extract into that of wildtype indicated sensitivity of quantiﬁca-
tion. These data show the dynamic range of sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) Flag immunoblot detection. (d) PSD95-
GFP was immunoprecipitated (IP) from Psd95TAP/GFP and negative
control (Psd95TAP/WT) forebrain extract supernatant (Input) with GFP
antibody. Top panel, SDS-PAGE GFP immunoblot of IP shows near
complete immunoprecipitation of all PSD95-GFP (Captured) from
Psd95TAP/GFP hybrid double mutant forebrain extracts. Second panel,
Flag immunoblot shows half PSD95-TAP co-precipitated with PSD95-
GFP, the remaining unbound PSD95-TAP was detected in the ﬂow-
through. Lower panel, Flag immunoblot of control IP (Psd95TAP/WT)
shows no PSD95-TAP was captured in the absence of GFP-tagged
PSD95. The total protein loaded for SDS immunoblot was normalized
across Input, Flow-through and Captured lanes by supplementing with
non-tagged (wildtype)samples. Representative data from triplicate
experiments shown. (e) Densitometric immunoblot quantiﬁcation of
PSD95-GFP (GFP) in GFP IP. The band intensities from triplicate
samples were measured and normalized to that of input. Error bars
indicate 1 SD. These data show essentially all the PSD95-GFP was
captured by GFP IP. (f) Densitometric immunoblot quantiﬁcation of
PSD95-TAP (Flag) inGFP IP (g,middle panel). Theband intensities from
triplicate samples were measured and normalized to that of input. Error
bars indicate 1 SD. These data show half the PSD95-TAP was co-
captured by PSD95-GFP immunoprecipitation. Thus, each 1.5-PSD95
supercomplex contains on averageadimer ofPSD95molecules. (g) 1.5-
PSD95 each containing two molecules of PSD95 were isolated in two
sequential steps: Flag immunoafﬁnity puriﬁcation (‘IAP’) followed by
GFP immunoprecipitation (‘IP’) fromPsd95TAP/GFPhybrid doublemutant
mice. Psd95TAP/WT mice were used as a negative control. PSD93 and
GluN1 were detected by SDS-PAGE immunoblot. These data show that
the subset of 1.5-PSD95 containing PSD93 and GluN1 each also
contain a dimer of PSD95.
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Fig. 3 Characterization of supercomplex subtypes. (a) Mutant mouse
screen of synaptic supercomplexes. BNP immunoblots of forebrain
extracts from ﬁve mutant mouse lines show genetic dependencies for
the assembly of 1.5-Kir2.3, 1.5-Arc, 1.5-IQsec2 and 1.5-Adam22. Each
panel contains duplicates of wildtype (WT) (lane 1,2, duplicates),
Psd95/ (lane 3,4), Psd93/ (lane 5,6), Glun2b2A(CTR)/2A(CTR) (lane
7,8), Glun2a2B(CTR)/2B(CTR) (lane 9,10), GluN2adelCTD. Immunoblotting
antibody is indicated below each panel (IB). Arrow indicates 1.5 MDa
bands. Molecular weight in MDa shown on right. Representative
results from triplicate experiments shown. (b) Table summarizing data
in Fig. 3a and recently published (Frank et al. 2016) showing the effect
of different mutations (columns) on distinct components of 1.5-PSD95
supercomplexes (rows). X, denotes assembly of supercomplex was
blocked by the mutation. -, denotes assembly of the supercomplex was
not blocked by the mutation. (c) Subunit-depletion of GluN2B and
PSD95 removes 1.5-Kir2.3. Extracts from Glun1TAP/TAP/Psd95GFP/GFP
double knockin mice were subunit-depleted with antibodies (shown in
lanes), then separated on BNP for immunoblotting with Kir2.3 antibody
to show 1.5-Kir2.3. Lanes; Input, total extract; immunodepleting
antibodies (lanes shown left to right), non-speciﬁc IgG, GFP, GluN2A,
GluN2B. Arrow indicates 1.5-Kir2.3. Molecular weight in MDa shown
on right. IB, immunoblotting antibody. (d) Subunit-depletion of PSD95
removes all 1.5-Arc. Extracts from Glun1TAP/TAP/Psd95GFP/GFP double
knockin mice were subunit-depleted with antibodies (shown in lanes)
then separated on BNP for immunoblotting with Arc antibody to show
1.5-Arc. Lanes; Input, total extract; immunodepleting antibodies (lanes
shown left to right), non-speciﬁc IgG, GFP, GluN2B. Arrow indicates
1.5-Arc. Molecular weight in MDa shown on right. IB, immunoblotting
antibody. (e) Subunit-depletion of PSD95 removes all 1.5-IQsec.
Extracts from Glun1TAP/TAP/Psd95GFP/GFP double knockin mice were
subunit-depleted with antibodies (shown in lanes), then separated on
BNP for immunoblotting with IQsec2 antibody to show 1.5-IQsec2. (f)
Subunit-depletion of PSD95 does not remove all Adam22. Extracts
from Glun1TAP/TAP/Psd95GFP/GFP double knockin mice were subunit-
depleted with antibodies (shown in lanes) then separated on BNP for
immunoblotting with Adam22 antibody to show 1.5-Adam22. (g)
Schematic showing extended family tree of ~1.5 MDa supercomplexes
that contain PSD95 and their relative abundance in the mouse
forebrain. The 1.5-PSD95 was divided into 1.5-NR and 1.5-Non-NR
subpopulations. PSD95 is 17-fold more abundant than GluN1. Since
~50% N-methyl D-aspartic acid receptors (NMDARs) interact with
PSD95 (Frank et al. 2016), 1.5-Non-NR is 34-fold more abundant than
1.5-NR (ratio indicated in blue). Each subpopulation was further
subdivided into those containing Kir2.3, IQseq2, Adam22 and Arc. The
distribution of 1.5-Kir2.3, 1.5-IQsec2, 1.5-Adam22 and 1.5-Arc (ex-
pressed as a ratio in blue) between 1.5-NR and 1.5-Non-NR were
estimated by densitometry of supercomplexes immunodepleted with
GluN2B and PSD95-EGFP respectively (see Fig. 3c–e).
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3 MDa, hereafter referred to for simplicity as 1.5-Kir2.3, 1.5-
IQsec2, 1.5-Arc, and 1.5-Adam22, respectively. We next
examined these protein complexes in a battery of mutant
mice to identify common and distinct genetic requirements of
supercomplex assembly.
Since we had previously demonstrated that the 1.5-NR
supercomplex is disrupted in Psd95/, Psd93/ and
Glun2b2A(CTR)/2A(CTR) mice (Frank et al. 2016), we tested
whether these mutants and two other NMDAR mutants
(Glun2a2B(CTR)/2B(CTR), Glun2adel-CTD) disrupted 1.5-Kir2.3,
1.5-Arc, 1.5-IQsec2 and 1.5-Adam22. Strikingly, as with
1.5-NR, 1.5-Kir2.3, 1.5-Arc and 1.5-IQsec2 supercomplexes
were each totally dependent on PSD95, but unlike 1.5-NR,
they were not totally dependent on PSD93 or GluN2B CTDs
(Fig. 3a). Thus, 1.5-NRs were genetically distinct from 1.5-
Kir2.3, 1.5-Arc and 1.5-IQsec2. Moreover, most 1.5-
Adam22 was not affected by any of the mutations, indicating
that it was genetically distinct from all the other supercom-
plexes. These data, summarized in a table (Fig. 3b), show
there is a ‘matrix of selectivity’ of mutations for different
supercomplexes where some mutations affect multiple
supercomplexes (e.g. Psd95), whereas other mutations have
no effect (GluN2A CTD). Together these results are
consistent with the interpretation that distinct PSD95 super-
complexes, each containing combinations of functionally
distinct proteins (ion channels, adhesion protein, signalling
enzymes), have speciﬁc genetic requirements for their
assembly.
The genetic experiments revealed further unexpected
evidence of subfamilies of PSD95 supercomplexes: we
observed a selective loss of half the population of 1.5-Kir2.3
in Glun2b2A(CTR)/2A(CTR) mice (Fig. 3a, lanes 7 and 8),
whereas all 1.5-Kir2.3 were missing in Psd95/ mice
(Fig. 3a, lanes 3 and 4). This raises the possibility that there
are two genetically separable populations of 1.5-Kir2.3:
those that were assembled with 1.5-NR into NMDAR-Kir2.3
ion channel-channel supercomplexes and those without
NMDARs (1.5-Non-NR). To test the possibility that there
is a subpopulation of 1.5-Kir2.3 containing NMDARs and
another lacking NMDARs, we examined extracts after
subunit-depletion of either NMDARs or PSD95. Immunode-
pleting PSD95 removed all 1.5-Kir2.3, whereas immunode-
pleting GluN2B removed 50% of the population of
1.5-Kir2.3 (Fig. 3c). These results are consistent with genetic
ﬁndings suggesting that half the population of 1.5-Kir2.3
interact with NMDARs within an ion channel-channel
supercomplex, while all other 1.5-Kir2.3 are in supercom-
plexes that lack NMDARs. Immunodepleting GluN2A
removed almost no 1.5-Kir2.3 (Fig. 3c), indicating that these
supercomplexes are likely composed of GluN1-GluN2B di-
heteromers.
As shown in Fig. 3g, these ﬁndings show a hierarchy of
organization of complexes into supercomplexes, in which
1.5-PSD95 can be divided into a Kir2.3-containing
subpopulations: those with NMDARs (1.5-NR) and those
lacking receptors (1.5-non-NR). To ask whether a similar
organization applies to other PSD95 interacting proteins, we
quantiﬁed the amount of Arc and IQsec2 in 1.5-NR and 1.5-
non-NR using the immunodepletion strategy. Densitometric
quantiﬁcation of 1.5-Arc and 1.5-IQsec2 BNP immunoblot
bands from GluN2B and PSD95 immunodepleted samples
indicated that all interact with PSD95 but that 4% and 5%
contain NMDARs, respectively (Fig. 3d and e). In contrast,
only 14% of 1.5-Adam22 was removed (Fig. 3f) from
PSD95-depleted samples, suggesting that only a very small
fraction of 1.5-Adam22 contains PSD95, again consistent
with genetic ﬁndings (Fig. 3a). Densitometric quantiﬁcation
of these data are summarized Fig. 3g (blue annotation)
showing the quantitative distribution of supercomplex sub-
types.
Purification of NMDAR-Kir2.3 ion channel-channel
supercomplex from the midbrain of TAP-tagged knockin
mice
The genetic requirements for supercomplex subtypes could
specify assembly anatomically within particular brain regions.
To explore whether supercomplexes reside in particular
synapses, we used an immunohistochemical survey of Kir2.3
to identify several brain regions enriched inKir2.3, fromwhich
we could isolate Kir2.3-NMDAR channel-channel supercom-
plexes by TAP-puriﬁcation using GluN1TAP/TAP mice. Kir2.3
resides in postsynaptic puncta enriched in rostroventral
midbrain and caudodorsal forebrain (Fig. 4a, left). TAP-
GluN1 puriﬁcation from isolated brain regions showed 1.5-
Kir2.3-NMDAR ion channel-channel supercomplexes were
enriched in rostroventral midbrain compared to the caudodor-
sal forebrain (Fig. 4, right). In accordance with the disruption
of 1.5-Kir2.3-NMDAR supercomplexes in Psd95/ mice
(Fig. 3a), Kir2.3 puncta were selectively disrupted in the
rostroventral midbrain of this mutant (Fig. 4b and c). No
anatomical difference between Psd95/ and wildtype cau-
dodorsal forebrains was detected.
Discussion
PSD95 is a central component of the postsynaptic terminal of
excitatory synapses with important roles in physiology and
behaviour. Although it is known to interact with many
proteins and form multiprotein complexes, the stoichiometry
of subunits and the speciﬁc protein interactions that assemble
these complexes is poorly understood in the intact animal.
We showed that almost all PSD95 resides within ~1.5 MDa
supercomplexes that on average each contain two molecules
of PSD95 in vivo. Our genetic and biochemical dissection of
PSD95 and its interactors suggest that subfamilies of
synaptic PSD95 supercomplexes are organized according to
a combination of genetic requirements that hierarchically
specify their composition.
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Although NMDAR and PSD95 both co-exist within
~1.5 MDa supercomplexes, 1.5-NR is a subset of 1.5-
PSD95. Accordingly, we quantiﬁed that there is 17-fold more
1.5-PSD95 than GluN1. Because ~50% of GluN1 is in 1.5-NR
and ~50% in 0.8-NR (ion channel complexes alone; lacking
PSD95) (Frank et al. 2016) then 1/34 of all PSD95 supercom-
plexes contain NMDAR in mouse forebrain (Fig. 3g). These
molar ratioswere from total forebrain anddiffer somewhat from
estimates using mass spectrometric approaches on Triton X-
100-resistant fractions of forebrain membranes (Cheng et al.
2006). It is likely each ~1.5 MDa supercomplex can accom-
modate a single tetrameric NMDAR. Since TAP-puriﬁed
NMDARs contain approximately equal amounts of PSD95 and
PSD93 (Frank et al. 2016) and the apparent dimeric oligomeric
state of PSD95 in vivo, we suggest 1.5-NR supercomplexes are
organized around a core platform containing a dimer of PSD95
and a dimer of PSD93 (Hsueh et al. 1997).
Supercomplexes containing PSD95 with or without
NMDARs are further subdivided into 1.5-Arc, 1.5-IQsec2,
1.5-Kir2.3 and 1.5-Adam22 supercomplex subfamilies. This
is consistent with the high degree of overlap of proteins
identiﬁed by mass spectrometry samples puriﬁed from
Grin1TAP and Psd95TAP mice (Frank et al. 2016). While
the similarity between these proteomes might suggest that
synaptic proteins associate promiscuously or by redundant
mechanisms, we show using several mouse mutations that
some supercomplexes have strict and selective genetic
dependencies for the assembly of their constituent proteins.
Interestingly, a similar genetic mechanism has been shown to
organize ankyrins, a family of axonal scaffold protein, that
cluster ion channels at the nodes of Ranvier (Ho et al. 2014).
The characterization of the Kir2.3-NMDAR ion channel-
channel supercomplexes and their neuroanatomical distribu-
tion highlights the potential physiological importance of
mechanisms controlling the organization of supercomplexes.
A functional interaction between inward-rectifying potassium
channels and NMDARs has been predicted to be the ‘perfect
couple’ for producing the necessary voltage bi-stability of ‘on’
and ‘off’ stateswithin the postsynapticmembrane (Major et al.
2013; Sanders et al. 2013). Our ﬁnding that a subset of 1.5-
Kir2.3 supercomplexes required the cytoplasmic domain of
GluN2B suggests that this domain may be directly involved
with themechanism of supercomplex formation between these
two channels. Kir2.3-NMDAR ion channel-channel super-
complexes were anatomically enriched within the ventral
midbrain regions but absent from the hippocampus and cortex.
Fig. 4 Neuroanatomically restricted assembly of Kir2.3-N-methyl
D-aspartic acid receptors (NMDAR) ion channel-channel supercom-
plexes. (a) Regional enrichment of Kir2.3 expression in mouse brain.
Left, mouse brain sagittal sections (lower) stained with Kir2.3 antibod-
ies and (upper) reference Nissl stain (Allen Brain Atlas). High
expression in rostroventral midbrain and caudodorsal forebrain shown
and boxed regions were dissected for TAP-puriﬁcation of NMDAR.
White arrow indicates boxed region of piriform cortex used in high-
magniﬁcation images in Fig. 4b and c. Scale bar, 1 mm. Right, BNP
immunoblots of TAP-puriﬁed receptors from dissected brain regions of
Glun1TAP/TAP mice as indicated. Left immunoblot probed with Flag
(TAP-GluN1) and right immunoblot probed with Kir2.3 showing 1.5-
Kir2.3-NMDAR ion channel-channel supercomplex enriched in rostro-
ventral midbrain. Filled arrow, 1.5-Kir2.3/NR. Molecular weight in MDa
shown on right. IB, immunoblotting antibody. (b) Kir2.3 localization in
layers of piriform cortex of wildtype (WT) and Psd95/ mice, including
layers 1a (L1a) and 2/3 (L2/3) of piriform cortex stained with antibodies
to Kir2.3 (green) and nuclear stain (DAPI, blue). White boxes indicate
regions further magniﬁed in Fig. 4c. Scale bar, 6 lm. (c) Kir2.3
localization requires Psd95. Higher magniﬁcation of boxed regions in
Fig. 4b shows synaptic localization of Kir2.3 is disrupted in Psd95/
mice. Sections double-stained with Kir2.3 (green, top) and pre-synaptic
marker synapsin1 (red, middle) antibodies and merged image (bot-
tom). White arrowheads show large Kir2.3 aggregates in Psd95/
mice. Scale bar, 4 lm. Right, histograms quantifying changes in
puncta size (upper graph) and density (lower graph) of piriform cortex
Kir2.3 quantiﬁed from triplicate experiments of Psd95/ and WT
sections. Error bar, 1 SD. **p ≤ 0.01; ***p ≤ 0.001.
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Thus, the mechanisms regulating the hierarchical organization
of synaptic supercomplex subfamilies appear to specify the
diversity of synapse subtypes.
Our results also shed light on the molecular organization of
synapses in vertebrate organisms and how their supercomplex
diversity arose. Two whole genome duplications occurred
~550million years ago in the vertebrate lineage resulting in the
generation of paralogs and an overall expansion of the
vertebrate synapse proteome (Emes et al. 2008; Emes and
Grant 2012). Our present results show selective effects of
paralog mutations in PSD95 and PSD93, as well as GluN2A
and GluN2B. Thus, the increase in paralogs has not simply
multiplied the number of vertebrate supercomplexes, but
rather, the diversiﬁcation of paralogs has resulted in selective
functions that restrict the diversity of supercomplexes.
The hierarchical organization of supercomplexes outlined
here is potentially generally relevant to the 66 proteins we
have previously reported to be distributed between 220
separable synaptic complexes and supercomplexes (Frank
et al. 2016). Indeed, it is possible that the number of distinct
complexes and supercomplexes identiﬁed using this bio-
chemical approach is underestimated because weakly asso-
ciated or very low abundance constituents may be refractory
to the use of detergents. We propose the hierarchy of genetic
requirements that gives rise to the assembly of distinct
supercomplex subfamilies may play an important role in
deﬁning synaptic function and synaptic subtypes of the brain.
Given the diversity of complexes and organization into sub-
families, we suggest there is potential to deﬁne a taxonomy
based on composition and its genetic determinants.
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